Experimental Study on Inhibition Effects of the XAF1 Gene against Lung Cancer Cell Proliferation

  • Yang, Wen-Tao (Department of Cardiothoracic Surgery, Second Affiliated Hospital, Soochow University) ;
  • Chen, Dong-Lai (Medicine Department of Soochow University) ;
  • Zhang, Fu-Quan (Department of Cardiothoracic Surgery, Second Affiliated Hospital, Soochow University) ;
  • Xia, Ying-Chen (Department of Cardiothoracic Surgery, Second Affiliated Hospital, Soochow University) ;
  • Zhu, Rong-Ying (Department of Cardiothoracic Surgery, Second Affiliated Hospital, Soochow University) ;
  • Zhou, Duan-Shan (Department of Cardiothoracic Surgery, Second Affiliated Hospital, Soochow University) ;
  • Chen, Yong-Bing (Department of Cardiothoracic Surgery, Second Affiliated Hospital, Soochow University)
  • Published : 2014.10.11


Objective: To investigate the effect of high expression of XAF1 in vivo or in vitro on lung cancer cell growth and apoptosis. Methods: 1. The A549 human lung cancer cell line was transfected with Ad5/F35 - XAF1, or Ad5/F35 - Null at the same multiplicity of infection (MOI); (hereinafter referred to as transient transfected cell strain); XAF1 gene mRNA and protein expression was detected by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting respectively. 2. Methyl thiazolyl tetrazolium (MTT) and annexin V-FITC/PI double staining were used to detect cell proliferation and apoptosis before and after infection of Ad5/F35 - XAF1 with Western blotting for apoptosis related proteins, caspase 3, caspase - 8 and PARP. 3. After the XAF1 gene was transfected into lung cancer A549 cells by lentiviral vectors, and selected by screening with Blasticidin, reverse transcription polymerase chain reaction (RT-PCR) and Western blotting were applied to detect mRNA and protein expression, to establish a line with a stable high expression of XAF1 (hereinafter referred to as stable expression cell strain). Twenty nude mice were randomly divided into groups A and B, 10 in each group: A549/XAF1 stable expression cell strain was subcutaneously injected in group A, and A549/Ctrl stable cell line stable expression cell strain in group B (control group), to observe transplanted tumor growth in nude mice. Results: The mRNA and protein expression of XAF1 in A549 cells transfected by Ad5/F35 - XAF1 was significantly higher than in the control group. XAF1 mediated by adenovirus vector demonstrated a dose dependent inhibition of lung cancer cell proliferation and induction of apoptosis. This was accompanied by cleavage of caspase -3, -8, -9 and PARP, suggesting activation of intrinsic or extrinsic apoptotic pathways. A cell strain of lung cancer highly expressing XAF1 was established, and this demonstrated delayed tumor growth after transplantation in vivo. Conclusion: Adenovirus mediated XAF1 gene expression could inhibit proliferation and induce apoptosis in lung cancer cells in vitro; highly stable expression of XAF1 could also significantly inhibit the growth of transplanted tumors in nude mouse, with no obvious adverse reactions observed. Therefore, the XAF1 gene could become a new target for lung cancer treatment.


  1. Aydiner A, Ciftci R, Karabulut S, et al (2013). Does beta-blocker therapy improve the survival of patients with metastatic non-small cell lung cancer? Asian Pac J Cancer Prev, 14, 6109-14.
  2. Chen YB, Shu J, Yang WT, et al (2011). XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer. Chin Med J, 124, 3238-43.
  3. Fong W G, Liston P, Rajcan-Separovic E, et al (2000). Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics, 70, 113-22.
  4. Itoh A, Okada T, Mizuguchi HA, et al (2003). Soluble CARSCF fusion protein improves adenoviral vector-mediated gene transfer to c-Kit-positive hematopoietic cells. J Gene Med, 5, 929-40
  5. Jung D, Néron S, Drouin M, et al (2005). Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector Ad5/F35. J Immunol Methods, 304, 78-7
  6. Kempken Steffen C, Fritzsche FR, Johannsen M, et al (2009). Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. BMC Cancer, 9, 276.
  7. Shibata T, Noguchi T, Takeno S, et al (2008). Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas. Ann Surg Oncol, 15, 3579-87.
  8. Oven Ustaalioglu BB, Unal OU, Turan N, et al (2013). Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences. Asian Pac J Cancer Prev, 14, 6287-92.
  9. Rea D, Havenga MJ, van Den Assem M, et al (2001). Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adeno-virus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol, 166, 5236-44
  10. Schroers R, Hildebrandt Y, Hasenkamp J, et al (2004). Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Exp Hematol, 32, 536-46
  11. Xiang DB, Chen ZT, Wang D, et al (2008). Chimeric adenoviral vector Ad5/F35- mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo. Cancer Gene Ther, 15, 625-35.
  12. Yan F, Gou L, Yang J, et al (2009). A novel pro-apoptosis gene PNAS4 that induces apoptosis in A549 human lung adenocarcinoma cells and inhibits tumor growth in mice. Biochimie, 91, 502-7.
  13. Yotnda P, Onishi H, Heslop HE, et al (2001). Efficient infection of primitive hemato- hematopoietic stem cells by modified adenovirus. Gene Ther, 8, 930-37

Cited by

  1. XIAP Associated Factor 1 (XAF1) Represses Expression of X-linked Inhibitor of Apoptosis Protein (XIAP) and Regulates Invasion, Cell Cycle, Apoptosis, and Cisplatin Sensitivity of Ovarian Carcinoma Cells vol.16, pp.6, 2015,
  2. vol.299, pp.3, 2015,
  3. Adenovirus encoding XAF-1 and TNF-α in the same open reading frame efficiently inhibits hepatocellular cancer cells vol.13, pp.6, 2016,